Molecular signals in B cell activation. II. IL-2-mediated signals are required in late G1 for transition to S phase after ionomycin and PMA treatment
- PMID: 2328536
- DOI: 10.1016/0008-8749(90)90149-l
Molecular signals in B cell activation. II. IL-2-mediated signals are required in late G1 for transition to S phase after ionomycin and PMA treatment
Abstract
We report that sustained increase of intracellular calcium ion concentration and protein kinase C (PKC) activation maintained throughout the G1 phase of cell cycle do not provide sufficient signals to cause S-phase entry in rabbit B cells, and that additional signals transduced by IL-2 and IL-2 receptor interaction are essential for G1 to S transition. We have shown earlier that rabbit B cells can be activated to produce IL-2 and express functional IL-2 receptors after treatment with ionomycin and PMA. Herein we have compared the response of rabbit PBLs, which contain about 50% T cells, with those of purified B cells. After activation with ionomycin or PMA, comparable numbers of PBLs and B cells entered the cell cycle; but DNA synthesis by the PBL cultures was three to four times higher than that of cultures of purified B cells. Interestingly, IL-2 production by the PBL cultures was also three to four times higher than in B cell cultures, suggesting an involvement of IL-2 in inducing DNA synthesis in these cells. The hypothesis that IL-2, which is produced in early G1, acts in late G1 and is required for G1 to S transition in B cells was supported by the following observations: (i) IL-2 production by B cells was detected as early as 6 hr after activation and preceded DNA synthesis by at least 24 hr. (ii) B cell blasts in G1 (produced by treatment of resting B cells with ionomycin and PMA) showed DNA synthesis in response to IL-2, but showed very little DNA synthesis in response to restimulation with ionomycin and PMA. (iii) A polyclonal rabbit anti-human IL-2 antibody caused nearly complete inhibition of DNA synthesis by B cells activated by ionomycin and PMA. (iv) A PKC inhibitor, K252b, inhibited DNA synthesis in ionomycin and PMA-stimulated cells if added at the beginning of culture but was not inhibitory if added 16 hr later. We conclude that increased [Ca2+]i and PKC activation are not sufficient signals for G1 to S transition in B cells; entry into S is signaled by IL-2, and IL-2-mediated signal transduction probably does not involve increased [Ca2+]i or PKC activation.
Similar articles
-
Molecular signals in B cell activation. I. Differential refractory effects of incomplete signaling by ionomycin or PMA relate to autocrine IL-2 production and IL-2R expression.Cell Immunol. 1990 May;127(2):483-96. doi: 10.1016/0008-8749(90)90148-k. Cell Immunol. 1990. PMID: 2328535
-
Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.J Immunol. 1986 May 15;136(10):3588-96. J Immunol. 1986. PMID: 3486215
-
Glycoprotein biosynthesis in B lymphocytes: induction of protein N-glycosylation, RNA synthesis, and DNA synthesis by phorbol ester plus ionomycin is blocked by protein kinase inhibitors.Arch Biochem Biophys. 1988 Nov 15;267(1):305-16. doi: 10.1016/0003-9861(88)90036-7. Arch Biochem Biophys. 1988. PMID: 2461680
-
Protein kinase C in IL-2 signal transduction.Immunol Res. 1997;16(4):355-74. doi: 10.1007/BF02786399. Immunol Res. 1997. PMID: 9439760 Review.
-
On-line studies of activation events in primary human T lymphocytes.Immunomethods. 1994 Apr;4(2):148-62. doi: 10.1006/immu.1994.1016. Immunomethods. 1994. PMID: 8069534 Review.
Cited by
-
Identification of a novel role for matrix metalloproteinase-3 in the modulation of B cell responses in multiple sclerosis.Front Immunol. 2022 Oct 26;13:1025377. doi: 10.3389/fimmu.2022.1025377. eCollection 2022. Front Immunol. 2022. PMID: 36389698 Free PMC article.
-
Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.J Clin Immunol. 1994 Mar;14(2):98-106. doi: 10.1007/BF01541342. J Clin Immunol. 1994. PMID: 8195318
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous